🎉 M&A multiples are live!
Check it out!

Ambu Valuation Multiples

Discover revenue and EBITDA valuation multiples for Ambu and other public comps.

See Ambu Valuation Multiples

Ambu Overview

About Ambu

Ambu AS is a Denmark based company providing single-use flexible endoscopes and is dedicated to optimizing hospital workflows and improving patient care. The company has created medtech solutions like resuscitators, anaesthesia masks, and electrodes and operates R&D, manufacturing and sales in Europe, North America and Rest of the world.


Founded

1937

HQ

Denmark
Employees

5.2K+

Website

ambu.com

Financials

LTM Revenue n/a

LTM EBITDA n/a

EV

$5.0B

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Ambu Financials

Ambu has a last 12-month revenue of n/a and a last 12-month EBITDA of n/a.

In the most recent fiscal year, Ambu achieved revenue of $753M and an EBITDA of $95.3M.

Ambu expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Ambu valuation multiples based on analyst estimates

Ambu P&L

FY 2022 FY 2023 FY 2024 LTM NTM
Revenue $621M $667M $753M n/a XXX
Gross Profit $357M $379M $447M XXX XXX
Gross Margin 57% 57% 59% XXX XXX
EBITDA $68.7M $86.5M $95.3M n/a XXX
EBITDA Margin 11% 13% 13% NaN% XXX
Net Profit $13.0M $23.5M $32.8M XXX XXX
Net Margin 2% 4% 4% XXX XXX
Net Debt $148M n/a n/a XXX XXX

Financial data powered by Morningstar, Inc.

Ambu Stock Performance

As of February 7, 2025, Ambu's stock price is DKK 134 (or $19).

Ambu has current market cap of DKK 35.6B (or $5.0B), and EV of DKK 35.6B (or $5.0B).

See Ambu trading valuation data

Ambu Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$5.0B $5.0B XXX XXX XXX XXX n/a

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

Ambu Valuation Multiples

As of February 7, 2025, Ambu has market cap of $5.0B and EV of $5.0B.

Ambu's trades at n/a LTM EV/Revenue multiple, and n/a LTM EBITDA.

Analysts estimate Ambu's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for Ambu and 10K+ public comps

Ambu Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $5.0B XXX XXX XXX
EV/Revenue n/a XXX XXX XXX
EV/EBITDA n/a XXX XXX XXX
P/E n/a XXX XXX XXX
P/E/Growth n/a XXX XXX XXX
EV/FCF n/a XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Ambu Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

Ambu Valuation Multiples

Ambu's NTM/LTM revenue growth is n/a

Ambu's revenue per employee for the last fiscal year averaged $0.1M, while opex per employee averaged $0.1M for the same period.

Over next 12 months, Ambu's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate Ambu's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for Ambu and other 10K+ public comps

Ambu Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth 13% XXX XXX XXX XXX
EBITDA Margin n/a XXX XXX XXX XXX
EBITDA Growth 10% XXX XXX XXX XXX
Rule of 40 (SaaS-only) n/a XXX XXX XXX XXX
Revenue per Employee $0.1M XXX XXX XXX XXX
Opex per Employee $0.1M XXX XXX XXX XXX
S&M Expenses to Revenue 29% XXX XXX XXX XXX
G&A Expenses to Revenue 12% XXX XXX XXX XXX
R&D Expenses to Revenue 6% XXX XXX XXX XXX
Opex to Revenue 47% XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Medical Devices
Consumer SaaS
Streaming Platforms
AdTech Software
Climate Tech
GRC Software
Developer Tools

Ambu Public Comps

See valuation multiples for Ambu public comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Philips XXX XXX XXX XXX XXX XXX
Perspective Therapeutics XXX XXX XXX XXX XXX XXX
Electromed XXX XXX XXX XXX XXX XXX
InfuSystem XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Ambu M&A and Investment Activity

Ambu acquired  XXX companies to date.

Last acquisition by Ambu was  XXXXXXXX, XXXXX XXXXX XXXXXX . Ambu acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Ambu

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About Ambu

When was Ambu founded? Ambu was founded in 1937.
Where is Ambu headquartered? Ambu is headquartered in Denmark.
How many employees does Ambu have? As of today, Ambu has 5.2K+ employees.
Who is the CEO of Ambu? Ambu's CEO is Ms. Britt Meelby Jensen.
Is Ambu publicy listed? Yes, Ambu is a public company listed on CSE.
What is the stock symbol of Ambu? Ambu trades under AMBU B ticker.
When did Ambu go public? Ambu went public in 1993.
Who are competitors of Ambu? Similar companies to Ambu include e.g. Philips, Perspective Therapeutics, Electromed, InfuSystem.
What is the current market cap of Ambu? Ambu's current market cap is $5.0B
What is the current revenue growth of Ambu? Ambu revenue growth between 2023 and 2024 was 13%.
Is Ambu profitable? Yes, Ambu is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.